EFPIA - NEWSLETTER

EFPIA Newsletter 12 April 2018

News

10 April 2018 10042018 PARADIGM, a unique collaboration for better patient engagement in medicines development...

PARADIGM stands for Patients Active in Research and Dialogues for an Improved Generation of Medicines and is funded...

10 April 2018 10042018 Joint Declaration on Pharmaceuticals in the Environment

We, the signatories of this declaration, recognise and understand the concerns regarding the presence of pharmaceuticals...

Blogs

11 April 2018 11042018 Falsified Medicines Directive - Long way travelled… still a long way to go…

The 9th of February 2019 looms large on the horizon, in fact the deadline for implementing the provisions of the Falsified...

12 April 2018 12042018 How surveillance programmes can help prevent a post-antibiotic apocalypse (Guest blog)...

A recent study found that since the year 2000, one-third of antibiotic resistance surveillance programme run in low...

Events

16 APR 2018

2018 China/EU Pharmaceutical Industry Forum Basel, Switzerland

An event jointly organised by EFPIA and CPIA

Learn more →

24 APR 2018

11042018 ‘The EU Manifesto on Influenza Vaccination – together reducing the burden... Brussels

The development of the EU Manifesto on Influenza Vaccination represents a tangible means of bringing different stakeholders...

Learn more →

What we are reading

Vytenis Andriukaitis: Big Data has enormous potential to advance medical research 04 April 2018 (The Parliament Magazine)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶